Anastrozole
CAS: 120511-73-1
Rif. IN-DA008Z0G
| 1g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 25g | Fuori produzione | ||
| 100mg | Fuori produzione | ||
| 500mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Anastrozole
Sinonimi:
- [u"2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)", u'anastrazole', u'Arimidex', u'ICI D1033', u'ZD 1033', u'ZD-1033', u'ZD1033', u'Zeneca ZD 1033', u'120511-73-1', u'Arimidex', u'anastrazole', u'Anastrozol', u'ZD-1033', u"2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile)", u'ZD1033', u'ZD 1033', u'ICI D1033', u'UNII-2Z07MYW1AZ', u'HSDB 7462', u'ICI-D1033', u'ICI-D 1033', u'2Z07MYW1AZ', u'CHEMBL1399', u'2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile', u"alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile", u'CHEBI:2704', u'YBBLVLTVTVSKRW-UHFFFAOYSA-N', u'C17H19N5', u'Anastrozole, 98%', u'NSC719344', u"2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)", u'NCGC00164619-01', u'Anastrole', u'Asiolex', u'DSSTox_CID_2607', u'2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile', u'DSSTox_RID_76656', u'DSSTox_GSID_22607', u"1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-", u'Zeneca ZD 1033', u'2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile', u'Arimidex (TN)', u'SMR000466301', u'Anastrozole [USAN:INN:BAN]', u'CAS-120511-73-1', u'SR-01000759390', u'AstraZeneca', u'Anastrozole (JAN/USAN/INN)', u'CCRIS 9352', u'Anastrozole [USAN:USP:INN:BAN]', u'tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile', u'Anastrozole(Arimidex)', u'Arimidex (AstraZeneca)', u'PubChem16625', u'SCHEMBL9726', u"2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)", u'ZINC941', u'MLS000759396', u'MLS001424217', u'MLS006011961', u'AC1L1D49', u'GTPL5137', u'DTXSID9022607', u'BDBM10015', u'AOB4816', u'EBD3898', u'QCR-114', u'BCPP000401', u'HMS2052M11', u'HMS2089N10', u'HMS2235M06', u'HMS3369K05', u'HMS3394M11', u'HMS3654I18', u'HMS3715B05', u'Pharmakon1600-01502278', u'ACT03222', u'BCP02090', u'Tox21_112238', u'Tox21_303568', u'BG0580', u'CA0164', u'MFCD00866298', u'NSC759855', u's1188', u'STL451008', u'AKOS015894980', u'Tox21_112238_1', u'AC-4234', u'API0001491', u'BCP9000301', u'CCG-101109', u'CS-0716', u'DB01217', u'KS-5052', u'MCULE-3029589501', u'NC00359', u'NSC-719344', u'NSC-759855', u'RP17921', u'SB17304', u"2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)", u'3-Phenylene]bis(2-methyl-propiononitrile', u'NCGC00164619-02', u'NCGC00164619-04', u'NCGC00257356-01', u'AJ-07942', u'AN-12153', u'BC202630', u'CC-24123', u'CPD000466301', u'HY-14274', u'LS-29563', u'SAM001246525', u'SC-15687', u'AB0012887', u'AB1009242', u'AX8041216', u'B1382', u'FT-0602851', u'ST24038362', u'SW197739-4', u'11A731', u'C08159', u'D00960', u'W-5140', u'AB00639929-06', u'AB00639929-08', u'AB00639929-09', u'AB00639929-10', u'AB00639929_11', u'AB00639929_13', u'A804526', u'C-18412', u'2;2"-[5-(1H-1;2;4-Triazol-1-ylmethyl)-1', u'I06-0021', u'SR-01000759390-4', u'SR-01000759390-5', u'Z1522566626', u"1,.alpha.,alpha.,alpha.',.alpha.'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-", u"1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)"]
- 1,3-Benzenediacetonitrile, α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-Benzenediacetonitrile,Alpha,Alpha,Alpha',Alpha'-Tetramethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-
- 1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
- 1-[3,5-Di-(1-Methyl-1-Cyano)-Ethyl]-Benzyl-1,2,4-Triazole
- 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
- 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)
- 2-[3-(1-Cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile
- 2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile
- 2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
- Vedi altri sinonimi
- Anastrazole
- Anastrol
- Anastrozol
- Anatrozole
- Arimidex
- Ici-D-1033
- Tetramethyl-5-(1H-1,2,4-Triazol-1Ylmethyl) 1,3-Benzenediacetionitrile
- Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile
- ZD-1033, ICI-D-1033, Arimidex
- Zd
- Zd-1033
- α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
- 1,3-Benzenediacetonitrile, α1,α1,α3,α3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)-
- zd
- α1,α1,α3,α3-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
293.3663
Formula:
C17H19N5
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3
InChI key:
YBBLVLTVTVSKRW-UHFFFAOYSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
